Modulation of morphine analgesia by site-specific N-methyl-D-aspartate receptor antagonists: Dependence on sex, site of antagonism, morphine dose, and time

Pain

Volumn 109, Issue 3, 2004, Pages 274-283

  Nemmani, Kumar V S ^a   Grisel, Judith E ^b   Stowe, Jennifer R ^b   Smith Carliss, Richard ^c   Mogil, Jeffrey S ^a  

^a MCGILL UNIVERSITY   (Canada)

^b FURMAN UNIVERSITY   (United States)

^c ENDO PHARMACEUTICALS INC   (United States)

Author keywords

Dextromethorphan; N Methyl D aspartate; Opioid; Sex differences

Indexed keywords

4 BENZYL ALPHA (4 HYDROXYPHENYL) BETA METHYL 1 PIPERIDINEPROPANOL; 7 CHLORO 4 HYDROXY 3 (3 PHENOXYPHENYL) 2 QUINOLONE; DECAHYDRO 6 PHOSPHONOMETHYL 3 ISOQUINOLINECARBOXYLIC ACID; DEXTROMETHORPHAN; DEXTRORPHAN; DIZOCILPINE; MORPHINE SULFATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANALGESIA; ANIMAL MODEL; ARTICLE; ATTENUATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; DRUG POTENTIATION; FEMALE; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; PAIN; PRIORITY JOURNAL; SEX DIFFERENCE; TAIL FLICK TEST;

ANIMALS; CENTRAL NERVOUS SYSTEM; DEXTROMETHORPHAN; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; ISOQUINOLINES; MALE; MICE; MORPHINE; PAIN; PHENOLS; PIPERIDINES; QUINOLONES; RECEPTORS, N-METHYL-D-ASPARTATE; SEX CHARACTERISTICS; TIME FACTORS;

EID: 2442503913     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2004.01.035     Document Type: Article

References (64)

1. Advokat C., Rhein F.Q. Potentiation of morphine-induced antinociception in acute spinal rats by the NMDA antagonist dextrorphan. Brain Res. 699:1995;157-160
2. Avenet P., Leonardon J., Besnard F., Graham D., Depoortere H., Scatton B. Antagonist properties of eliprodil and other NMDA receptor antagonists at rat NR1A/NR2A and NR1A/NR2B receptors expressed in Xenopus oocytes. Neurosci Lett. 223:1997;133-136
3. Baker A.K., Hoffmann V.L., Meert T.F. Dextromethorphan and ketamine potentiate the antinociceptive effects of mu- but not delta- or kappa-opioid agonists in a mouse model of acute pain. Pharmacol Biochem Behav. 74:2002;73-86
4. Baker A.K., Hoffmann V.L., Meert T.F. Interactions of NMDA antagonists and an alpha 2 agonist with mu, delta and kappa opioids in an acute nociception assay. Acta Anaesthesiol Belg. 53:2002;203-212
5. Bell R.F. Low-dose subcutaneous ketamine infusion and morphine tolerance. Pain. 83:1999;101-103
6. Belozertseva I.V., Dravolina O.A., Neznanova O.N., Danysz W., Bespalov A.Y. Antinociceptive activity of combination of morphine and NMDA receptor antagonists depends on the inter-injection interval. Eur J Pharmacol. 396:2000;77-83
7. Ben-Abraham R., Weinbroum A.A. Dextromethorphan in chronic pain: a disappointing update. Isr Med Assoc J. 2:2000;708-710
8. Bernardi M., Bertolini A., Szczawinska K., Genedani S. Blockade of the polyamine site of NMDA receptors produces antinociception and enhances the effect of morphine, in mice. Eur J Pharmacol. 298:1996;51-55
9. Bhargava H.N. Enhancement of morphine actions in morphine-naive and morphine-tolerant mice by LY 235959, a competitive antagonist of the NMDA receptor. Gen Pharmacol. 28:1997;61-64
10. Bilsky E.J., Inturrisi C.E., Sadee W., Hruby V.J., Porreca F. Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective mu or delta opioid agonists in mice. Pain. 68:1996;229-237
11. Boyce S., Wyatt A., Webb J.K., O'Donnell R., Mason G., Rigby M., Sirinathsinghji D., Hill R.G., Rupniak N.M. Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: correlation with restricted localisation of NR2B subunit in dorsal horn. Neuropharmacology. 38:1999;611-623
12. Chang F.L., Wu C.T., Yeh C.C., Lin T.C., Ho S.T., Wong C.S. Postoperative intramuscular dextromethorphan injection provides postoperative pain relief and decreases opioid requirement after hemorrhoidectomy. Acta Anaesthesiol Sin. 37:1999;179-183
13. Chesler E.J., Wilson S.G., Lariviere W.R., Rodriguez-Zas S.L., Mogil J.S. Identification and ranking of genetic and laboratory environment factors influencing a behavioral trait, thermal nociception, via computational analysis of a large data archive. Neurosci Biobehav Rev. 26:2002;907-923
14. Chia Y.Y., Liu K., Chow L.H., Lee T.Y. The preoperative administration of intravenous dextromethorphan reduces postoperative morphine consumption. Anesth Analg. 89:1999;748-752
15. Chien C.-C., Pasternak G.W. Sigma antagonists potentiate opioid analgesia in rats. Neurosci Lett. 190:1995;137-139
16. Chizh B.A., Headley P.M., Tzschentke T.M. NMDA receptor antagonists as analgesics: focus on the NR2B subtype. Trends Pharmacol Sci. 22:2001;636-642
17. Chou Y.C., Liao J.F., Chang W.Y., Lin M.F., Chen C.F. Binding of dimemorfan to sigma-1 receptor and its anticonvulsant and locomotor effects in mice, compared with dextromethorphan and dextrorphan. Brain Res. 821:1999;516-519
18. Craft R.M. Sex differences in opioid analgesia: 'from mouse to man'. Clin J Pain. 19:2003;175-186
19. Dhawan B.N., Cesselin F., Raghubir R., Reisine T., Bradley P.B., Portoghese P.S., Hamon M. International Union of Pharmacology. XII. Classification of opioid receptors. Pharmacol Rev. 48:1996;567-592
20. Elliott K., Minami N., Kolesnikov Y.A., Pasternak G.W., Inturrisi C.E. The NMDA receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids. Pain. 56:1994;69-75
21. Elliott K., Kest B., Man A., Kao B., Inturrisi C.E. N-methyl-D-aspartate (NMDA) receptors, mu and kappa opioid tolerance, and perspectives on new analgesic drug development. Neuropsychopharmacology. 13:1995;347-356
22. Goldblum R. Long-term safety of MorphiDex. J Pain Symptom Manage. 19:2000;S50-S56
23. Grace R.F., Power I., Umedaly H., Zammit A., Mersiades M., Cousins M.J., Mather L.E. Preoperative dextromethorphan reduces intraoperative but not postoperative morphine requirements after laparotomy. Anesth Analg. 87:1998;1135-1138
24. Heiskanen T., Hartel B., Dahl M.L., Seppala T., Kalso E. Analgesic effects of dextromethorphan and morphine in patients with chronic pain. Pain. 96:2002;261-267
25. Hernandez S.C., Bertolino M., Xiao Y., Pringle K.E., Caruso F.S., Kellar K.J. Dextromethorphan and its metabolite dextrorphan block alpha3beta4 neuronal nicotinic receptors. J Pharmacol Exp Ther. 293:2000;962-967
26. Holtman J.R. Jr, Jing X., Wala E.P. Sex-related differences in the enhancement of morphine antinociception by NMDA receptor antagonists in rats. Pharmacol Biochem Behav. 76:2003;285-293
27. Kavaliers M., Choleris E. Sex differences in N-methyl-D-aspartate involvement in kappa opioid and non-opioid predator-induced analgesia in mice. Brain Res. 768:1997;30-36
28. Kavaliers M., Galea L.A.M. Sex differences in the expression and antagonism of swim stress-induced analgesia in deer mice vary with the breeding season. Pain. 63:1995;327-334
29. Kest B., Marek P., Liebeskind J.C. The specific N-methyl-D-aspartate (NMDA) receptor antagonist MK-801 blocks U-50, 488, but not morphine antinociception. Brain Res. 589:1992;139-142
30. Kolesnikov Y.A., Ferkany J., Pasternak G.W. Blockade of mu and kappa 1 opioid analgesic tolerance by NPC17742, a novel NMDA antagonist. Life Sci. 53:1993;1489-1494
31. Kozela E., Popik P. The effects of NMDA receptor antagonists on acute morphine antinociception in mice. Amino Acids. 23:2002;163-168
32. Kozela E., Danysz W., Popik P. Uncompetitive NMDA receptor antagonists potentiate morphine antinociception recorded from the tail but not from the hind paw in rats. Eur J Pharmacol. 423:2001;17-26
33. Lipa S.M., Kavaliers M. Sex differences in the inhibitory effects of the NMDA antagonist, MK-801, on morphine and stress-induced analgesia. Brain Res Bull. 24:1990;627-630
34. Lutfy K., Hurlbut D.E., Weber E. Blockade of morphine-induced analgesia and tolerance in mice by MK-801. Brain Res. 616:1993;83-88
35. Lutfy K., Doan P., Nugyen M., Weber E. ACEA-1328, an NMDA receptor antagonist, increases the potency of morphine and U50, 488H in the tail flick test in mice. Pharmacol Res. 38:1998;453-460
36. Lutfy K., Doan P., Weber E. ACEA-1328, a NMDA receptor/glycine site antagonist, acutely potentiates antinociception and chronically attenuates tolerance induced by morphine. Pharmacol Res. 40:1999;435-442
37. Maeda T., Kishioka S., Fan X., Fukazawa Y., Shimizu N., Ozaki M., Yamamoto H. Effects of diltiazem and MK-801 on morphine analgesia and pharmacokinetics in mice. Neurosci Lett. 326:2002;216-218
38. Mao J. NMDA and opioid receptors: their interactions in antinociception, tolerance and neuroplasticity. Brain Res Brain Res Rev. 30:1999;289-304
39. 1 Receptor modulation of opioid analgesia in the mouse. J Pharmacol Exp Ther. 300:2002;1070-1074
40. Mogil J.S., Sternberg W.F., Kest B., Marek P., Liebeskind J.C. Sex differences in the antagonism of swim stress-induced analgesia: effects of gonadectomy and estrogen replacement. Pain. 53:1993;17-25
41. Mogil J.S., Wilson S.G., Chesler E.J., Rankin A.L., Nemmani K.V., Lariviere W.R., Groce M.K., Wallace M.R., Kaplan L., Staud R., Ness T.J., Glover T.L., Stankova M., Mayorov A., Hruby V.J., Grisel J.E., Fillingim R.B. The melanocortin-1 receptor gene mediates female-specific mechanisms of analgesia in mice and humans. Proc Natl Acad Sci USA. 100:2003;4867-4872
42. Monck N. Morphine/dextromethorphan-endo: E 3231, Morphidex. Drugs R D. 4:2003;55-56
43. Netzer R., Pflimlin P., Trube G. Dextromethorphan blocks N-methyl-D-aspartate-induced currents and voltage-operated inward currents in cultured cortical neurons. Eur J Pharmacol. 238:1993;209-216
44. Parsons C.G. NMDA receptors as targets for drug action in neuropathic pain. Eur J Pharmacol. 429:2001;71-78
45. Parsons C.G., Danysz W., Bartmann A., Spielmanns P., Frankiewicz T., Hesselink M., Eilbacher B., Quack G. Amino-alkyl-cyclohexanes are novel uncompetitive NMDA receptor antagonists with strong voltage-dependency and fast blocking kinetics: in vitro and in vivo characterization. Neuropharmacology. 38:1999;85-108
46. Pasternak G.W., Kolesnikov Y.A., Babey A.M. Perspectives on the N-methyl-D-aspartate/nitric oxide cascade and opioid tolerance. Neuropsychopharmacology. 13:1995;309-313
47. Popik P., Kozela E., Danysz W. Clinically available NMDA receptor antagonists memantine and dextromethorphan reverse existing tolerance to the antinociceptive effects of morphine in mice. Naunyn Schmiedebergs Arch Pharmacol. 361:2000;425-432
48. Porter R.H., Greenamyre J.T. Regional variations in the pharmacology of NMDA receptor channel blockers: implications for therapeutic potential. J Neurochem. 64:1995;614-623
49. Price D.D., Mayer D.J., Mao J., Caruso F.S. NMDA-receptor antagonists and opioid receptor interactions as related to analgesia and tolerance. J Pain Symptom Manage. 19:2000;S7-S11
50. Ramachander G., Bapatla K.R., Emele J.F. Sex differences in plasma half-life of dextrorphan in rats administered dextromethorphan. J Pharm Sci. 67:1978;1326-1327
51. Redwine K.E., Trujillo K.A. Effects of NMDA receptor antagonists on acute μ-opioid analgesia in the rat. Pharmacol Biochem Behav. 76:2003;361-372
52. Rose J.B., Cuy R., Cohen D.E., Schreiner M.S. Preoperative oral dextromethorphan does not reduce pain or analgesic consumption in children after adenotonsillectomy. Anesth Analg. 88:1999;749-753
53. Saucier D.M., Kavaliers M. Antagonistic effects of the selective, competitive N-methyl-D-aspartate (NMDA) receptor antagonist, NPC 12626, on kappa opiate-induced analgesia in male deer mice. Brain Res. 637:1994;292-296
54. Sternberg W.F., Mogil J.S., Kest B., Page G.G., Leong Y., Yam V., Liebeskind J.C. Neonatal testosterone exposure influences neurochemistry of swim stress-induced analgesia in adult mice. Pain. 63:1996;321-326
55. Suh H.W., Song D.K., Kim Y.H., Yoo J.S., Tseng L.F. Differential antagonism by MK-801 against antinociception induced by opioid receptor agonists administered supraspinally in mice. Eur J Pharmacol. 263:1994;217-221
56. Suh H.W., Song D.K., Choi Y.S., Kim Y.H. Multiplicative interaction between intrathecally and intracerebroventricularly administered morphine for antinociception in the mouse: involvement of supraspinal NMDA but not non-NMDA receptors. Life Sci. 56:1995;PL181-PL185
57. Tallarida R.J., Murray R.B. Manual of pharmacologic calculation. 1981;Springer, New York
58. Wadhwa A., Clarke D., Goodchild C.S., Young D. Large-dose oral dextromethorphan as an adjunct to patient-controlled analgesia with morphine after knee surgery. Anesth Analg. 92:2001;448-454
59. Weinbroum A.A., Rudick V., Paret G., Ben-Abraham R. The role of dextromethorphan in pain control. Can J Anaesth. 47:2000;585-596
60. Weinbroum A.A., Gorodetzky A., Nirkin A., Kollender Y., Bickels J., Marouani N., Rudick V., Meller I. Dextromethorphan for the reduction of immediate and late postoperative pain and morphine consumption in orthopedic oncology patients: a randomized, placebo-controlled, double-blind study. Cancer. 95:2002;1164-1170
61. Wilson S.G., Mogil J.S. Measuring pain in the (knockout) mouse: big challenges in a small mammal. Behav Brain Res. 125:2001;65-73
62. Wong C.S., Wu C.T., Yu J.C., Yeh C.C., Lee M.M., Tao P.L. Preincisional dextromethorphan decreases postoperative pain and opioid requirement after modified radical mastectomy. Can J Anaesth. 46:1999;1122-1126
63. Wu D., Otton S.V., Kalow W., Sellers E.M. Effects of route of administration on dextromethorphan pharmacokinetics and behavioral response in the rat. J Pharmacol Exp Ther. 274:1995;1431-1437
64. Wu C.T., Yu J.C., Yeh C.C., Liu S.T., Li C.Y., Ho S.T., Wong C.S. Preincisional dextromethorphan treatment decreases postoperative pain and opioid requirement after laparoscopic cholecystectomy. Anesth Analg. 88:1999;1331-1334